1 | P a g e

“Experts predict that the CBD oil market will have a compound

annual growth rate of 90% through 2024. With new methods

for producing CBD and the realization of the benefits of

CBD oil, it’s easy to understand why CBD oil will be a

significant part of the cannabis industry boom.”

Brightfield Group, LLC. | www.brightfieldgroup.com

2 | P a g e

Confidentiality Statement and Legal Disclaimer

The provisions of this plan are privileged and confidential. Unauthorized reproduction or distribution of this Business Plan Summary or any of

its contents in any form or under any circumstances without prior written consent is prohibited. The Recipient is responsible for returning all

copies of this Business Plan Summary immediately upon request by Jatro Renewables, Inc. (also referred to the Company or Jatro).

The information contained herein is: (i) provided by the principal founders of the business and (ii) publicly available from directories,

publications and websites, as mentioned in the body and the footnotes where possible or appropriate. In some cases, non-publicly available

information was used, including independent research, studies or paid services from individuals and organizations.

While the information set forth herein is deemed by Jatro to be accurate, Jatro shall not be held liable for the accuracy of or any omissions

from this Business Plan Summary or for any other written or oral communication transmitted to the Recipient and any other party in the

course of its evaluation of transactions involving Jatro.

The information contained in the plan will require careful scrutiny, verification and due diligence efforts from the Recipients of the plan. Any

person or entity seeking to make an investment in the business should not rely on the information set forth in the plan as complete. In

addition, the analyses contained herein do not claim to be appraisals of the assets, or the valuation of any entity.

The business makes no guarantees regarding any benefits received from investment, nor the legal, tax or accounting effects of any

transaction; and this Plan does not constitute an offer to sell, or a solicitation of an offer to buy securities. In furnishing the Business Plan

Summary, Jatro undertakes no obligation to provide Recipients of the Business Plan Summary with access to any additional information or to

update this Business Plan Summary or to correct any inaccuracies that may be contained herein.

There exists substantial information with respect to the hemp business and its future prospects, and there are a substantial number of risks

associated with an investment in this business, which are not set forth in the plan.

Furthermore, the potential fulfillment of ‘forward looking statements’ contained in the plan are subject to change due to unexpected events,

market shifts, or circumstances that cannot be known at this time. Forward looking statements are based on expectations, estimates and

projections at the time the statements were made that involve a number of economic, business, and numerous risks and uncertainties which

could cause actual results or events to differ materially from those presently anticipated.

Forward looking statements in the plan maybe identified through the use of words such as, but not exclusively to: "expects," "will,"

"anticipates," "estimates," "believes," or statements indicating certain actions "may," "could," or "might" occur. Such estimates and

projections are subject to significant uncertainties beyond the control of the Company. Although such projections are believed to be realistic,

no representations are made as to their ultimate attainability.

3 | P a g e

TABLE OF CONTENTS

Page

THE OPPORTUNITY 3

FUNDING /USE OF PROCEEDS 3

KEY INVESTMENT CONSIDERATIONS 5

COMPANY BACKGROUND 5

PRODUCT DISTRIBUTION 6

KEY MANAGEMENT 6

START-UP CASH FLOW ANALYSIS 7

DETAILED PROJECT TIME-LINE 8

ABOUT CBD 8

BENEFITS OF CBD 8

APPENDIX A: Hemp-CBD key findings 9

APPENDIX B: Oil extraction system 12

APPENDIX C: Production time-line detail 13

APPENDIX D: Proforma (15% annual growth) 14

Proforma (25% annual growth) 15

Proforma (40% annual growth) 16

APPENDIX E: CBD Product Gallery 17

APPENDIX F: CBD Cultivation Option 18

4 | P a g e

THE OPPORTUNITY

Jatro Renewables (Jatro) is establishing an autonomous subsidiary division to focus exclusively on

designing and manufacturing oil extraction equipment for the hemp industry — a market complimentary

to Jatro’s own core business of engineering and operating biodiesel plants since 2004.

Now that the 2018 Farm Bill makes it legal to cultivate and sell hemp-related products in all 50 states —

the agriculture industry is moving quietly into top gear to address this much heralded opportunity.

The first most conspicuous and fastest developing market is the use of hemp oil as a medicine. In 2018,

according to research firm Brightfield Group, $887 million was spent on cannabidiol (CBD) oil products,

and the firm forecasts a 90% compound growth rate over the next five years. In addition, they expect the

market for all hemp derived products will reach $22b/year by 2024.

This is the market Jatro is addressing in several

stages: Stage I, has been underway since June

2018, and is the continuing development of the

Company’s hemp oil extraction process. The

objective is to have a highly scalable system with

a lower capex than those currently in use with

higher oil yields, lower processing costs and use

less energy. Stage II will follow when funding is

complete and when the Company will launch its

retail product line, but using oils processed by others temporarily. The company “CBD Experts” is

supporting that effort (www.cbdhempexperts.com).

Then, within nine months, at Stage III, Jatro will leverage its own technological and cost advantages and

produce all its CBD oil in-house.

Currently, Jatro is conducting its research on their pilot system at their engineering facility in Miamisburg,

OH. Initial oil samples have been tested by SC Labs, a California certified laboratory in Santa Cruz, and

early results show great promise well within typical with industry parameters.

CBD has been shown to help with everything from PTSD and anxiety to MS, epilepsy, relieving skin

conditions, improving sleep and more — all without getting you intoxicated as CBD has <0.3% THC, a legal

requirement for cultivation under rules of the Farm Bill (See APPENDIX A, Page 9).

FUNDING /USE OF PROCEEDS

To move ahead with the project, Jatro is seeking funds of $675k. The proceeds will be used to complete its

hemp oil extraction process, develop the retail market for CBD oil-based products, and for CBD product

inventory, promotion, and working capital.

Jatro plans to pay dividends based on members’ equity when margins allow and approved by Board of

Directors. And from reports by existing retailers selling CBD products and industry projections, annual

growth rates have been in the double digits, so Jatro is expecting to be cash flow positive within 12 to 18

months.

5 | P a g e

KEY INVESTMENT CONSIDERATIONS

With the recent passage of the 2018 Farm Bill in December, growing hemp and making products from it is

essentially a totally new industry in the United States. Properly addressed this becomes literally the

opportunity of a lifetime. Great! So how is the Company positioned vs. the competition?

First, Jatro will have the most efficient system for extracting and processing hemp oil for almost all

CBD-based products entering the market

Jatro will have total control over its product quality and delivery — the most important aspect of

any product, especially for medicines. This includes meeting Federal and State governments

requiring certain reporting and other rules, such as THC levels be below 0.03%

Jatro’s technology includes self-sufficient portable oil extraction equipment for taking to hemp

growers temporarily. This reduces freight and storage costs as hemp is very voluminous

As a vertically integrated company it will reduce middlemen, delays and other costs

Jatro has multiple sales channels to mitigate depressed sales of any one (see diagram below)

Regarding customer relationship management (CRM), Jatro management have had deep

experience both in cellular phone service and on-line consumer recurring sales and appreciate the

nuances for keeping customers satisfied, and ultimately retaining them

To mitigate churn (loss of customers) Jatro will institute loyalty programs where individuals sign up

for one or more years of product at a discount, and delivered on a set schedule

Not treating customers as just a transaction or deal, but segmenting them and understanding each group’s specific needs and tailoring programs to meet them

Because of these advantages, Jatro expects to be dominant in CBD product sales within 2 years.

COMPANY BACKGROUND

The Jatro Renewables’ management team has many years

experience in the biofuels industry as designers and operators of

biodiesel plants. This includes having installed or re-engineening 18

plants since 2004. Today two plants are using Jatro’s new patented

supercritical technology developed in 2015 (the photo at left is a

Jatro biodiesel plant co-located at CHS, Inc’s 110 million gallons per

year ethanol plant in Illinois).

Jatro’s process significantly increases profit margins for producers as it allows conversion of low cost

feedstocks (such as municipal waste) into biodiesel without the use of expensive catalysts.

Venturing into CBD production and its R&D to enhance the processing of hemp to oil is well within Jatro’s

purview, especially since the Company has long understood oil chemistry and quality control issues.

6 | P a g e

PRODUCT DISTRIBUTION

KEYMMANAGEMENT

Jatro is led by Raj Mosali, CEO (Founder), an electrical engineer by education with a M.S. degree from

Florida Atlantic University in Boca Raton, FL. His main function is managing the day to day operations of

Jatro as well as setting its strategic direction. He has had 21 years experience with large corporate

business environment with leadership positions. Raj has been instrumental in developing two key

technologies in biodiesel technology: the first in 2006 allowing feedstock oils to be processed to 15% free

fatty acid (FFA) from the then current 2% level. Then in 2015 advancing the technology to handle up to

100% FFA oils. On the latter, in 2017, Jatro was awarded a $4m grant by the California Energy Commission

for use of this process on a biodiesel project.

Leading technology development is John Cooper, Head Chief Chemist, who provides a wealth of

experience dealing with biodiesel and now leveraging that knowledge to develop more efficient methods

of extracting oil from the hemp plant and critical post-processing of its compounds.

For business development and marketing, Ian Lawson, Marketing and Director of Business Development,

brings a wealth of creativity to Jatro. He has a B.S. in Communications from Boston University and has

worked in the biodiesel industry since 2007. Since 1978, he has owned four businesses, all since sold,

three operating successfully today. In the early eighties he was with the ARCO Oil Company where he

7 | P a g e

managed national marketing for their new photovoltaic products. In the mid-nineties he moved to

telecommunications and his company designed and manufactured cellular phone services and marketed

nationally.

Heading up accounting is Sabrina Pennington, Director of Accounting, who has had many years managing

accounting departments in a number of high-profile companies.

START-UP CASH FLOW & MARGIN ANALYSIS¹

The table below shows projected revenue and margins, starting in 2019. From early 2020 Jatro’s own

production unit will become operational and where margins will increase substantially.

The start-up product mix consists of about 5 to 7 popular SKUs that show the most promise. Among them:

tinctures, topicals, creams, capsules, vapes, gummies and dog chews (see APPENDIX E).

INVESTMENT

2 Q2 2019 3Q 4Q 2020 2021

Equipment

$150,000 Working Capital

$525,000

Sub-Total Capex

$675,000

CASH ON HAND $525,000 510,613 536,784 624,527 971,498

REVENUE # of Items 1 g Tinctures

2,304 3,253 4,535 14,948 17,190

Sub-Total Revenue $75 $172,783 $243,954 $340,161 $1,121,111 $1,224,814

COST OF GOODS SOLD CBD Tinctures $27 62,202 87,823 122,458 403,600 464,140

Packing

19,968 24,960 24,960 inc.² inc.²

Sub-Total COGS 82,170 112,783 147,418 151,592 163,744

RETAIL COSTS Internet Advertising

40,500 40,500 40,500 inc.² inc.²

Sub-Total Retail 40,500 40,500 40,500 194,400 204,800

G&A. Engineering/R&D

12,000 12,000 12,000 66,000 69,300

Management and G&A

52,500 52,500 52,500 362,148 432,286

Sub-Total G&A and Engg 64,500 64,500 64,500 428,148 501,586

TOTAL COSTS 187,170 217,783 252,418 774,140 870,129

EBITDA

-14,387 26,171 87,743 346,972 354,685

% of Revenue

-8% 11% 26% 31% 29%

ENDING CASH $510,613 $536,784 $624,527 $971,498 $1,326,183

Notes

(1) See 5-Year Proforma, APPENDIX D, pages 14-16

(2) Cost included in Sub-Total COGS and Sub-Total Retail

8 | P a g e

PRODUCTION TIME-LINE

HEMP INDUSTRY OVERVIEW

A carbohydrate economy reduces pollution, builds stronger rural communities and supports a rooted

farmer-owned processing and manufacturing sector:

Hemp offers high tonnage of biomass over a one to three growing seasons per year

(depending on latitude and elevation) at (2 to-4 tons per acre)

Hemp has excellent opportunities for co-and by-products in seed and fiber processing,

Hemp enhances environmental values on the farm, and thus is consistent with the

objectives of using plants for energy.

Some value-added end uses for co-and by-products for industrial hemp include:

Composites

Fine paper

Nitrogen-rich fertilizer

Plastics

Fabrics

Polymers,

Seed products for nutrition for food and feed

Industrial oil markets for biodiesel, renewable diesel and ethanol etc.

For rural economies needing to diversify, for small family farms needing to create additional value from

their produce, and for everyone sick of the choking smog created by our millions of cars, biodiesel and

ethanol production deserves serious consideration.

*

9 | P a g e

APPENDIX A

CBD SUMMARY

CBD, is the non-psychoactive cannabinoid found in the cannabis sativa plant. Over the past couple of years

it has had a huge surge in popularity. It is unlike tetrahydrocannabinol (THC), which comes from a

different strain of the same plant that gives weed its signature psychoactive effect.

Previous to the Farm Bill, CBD products have been available mostly in head shops, with a few doctors

recommending it for various maladies.

However, in 2017 and 2018, the products spread to natural food stores, beauty aisles, cafés, doctors’

offices . . . and of course the internet!

(btw, the term “hemp” is used for cannabis sativa strains containing less than <0.3% THC; the label

“marijuana” refers to strains with over >0.3% and typically up to ~30% THC.

BENEFITS OF CBD

HelloMD and the Brightfield Group conducted the largest CBD market usage study to date. This study includes 2,400 HelloMD members of their total community of 150,000 customers.

Key findings for hemp-derived CBD users are;

59 percent of consumers are female

Anxiety is the top medical condition to treat

The majority of users purchase from dispensaries

59 percent of consumers prefer oil cartridges/vaping

More than 50 percent use CBD products daily

Consumers use CBD products to provide the best medical relief

“In an effort to shed light onto the opaque market, Brightfield Group, in combination with HelloMD, has

collected data from over 2,400 HelloMD medicinal cannabis community members from the United States

(primarily California) and abroad. The resulting analysis provides insight into their experiences and

perceptions of CBD products – both hemp-derived and marijuana-derived,” states the report.

HEMP-CBD KEY FINDINGS

Overall, this CBD market study demonstrates that consumers find effectiveness in treating anxiety,

insomnia, joint pain and depression. Throughout the study, rates of CBD usage, CBD user profiles, medical

conditions treated by CBD, brand preferences, and CBD customer satisfaction were all determined for CBD

dominant users, marijuana-derived CBD only users, hemp-derived CBD users, and THC dominant users.

For the sake of Infinite CBD being an industrial hemp-derived CBD isolate company, these findings

primarily reflect hemp-derived CBD users.

10 | P a g e

User Demographics

The majority of hemp-derived CBD users are female, making up 59 percent of users. 31 percent are

between the ages of 35 and 49 with people age 26-34 and 50-60 following at 22 percent.

According to Infinite CBD reports, our demographics are similar to these statistics. The majority of our

users are women but 32 percent are between the ages of 25 and 34.

Preferred Consumption Method

The HelloMD and Brightfield Group survey concludes that vaping is the preferred method of consumption.

Next is a topical. Consumers would then prefer a high CBD flower/strain, followed by tinctures and

edibles.

For Infinite CBD, over the past three months Internet retailerAbsolute Zero has been their most popular

product. This is a smokable and users can either dab or vape. Vaping offers users a fast and effective relief

that is discrete. Our 5000mg droppers were the next most sold product over the past three months. These

can be used as a topical or as a tincture.

11 | P a g e

Of the 2,400 participants, 71 percent use hemp-derived CBD products for anxiety.

In a double blind study, 12 participants took 600 mg of CBD while 12 participants took a

placebo. Results conclude that those who took CBD had significantly reduced anxiety, cognitive

impairment and discomfort in their speech performance, and significantly decreased alert in their

anticipatory speech.

Insomnia

64 percent consume for insomnia. During a Brazilian study, researchers at Escola Paulista de Medicina in

São Paulo completed a study where 15 insomniacs were administered 40 mg to 160 mg of CBD, a placebo,

or nitrazepam. Results show that the highest dose of CBD increased sleep. Additional research studies

describe CBD as an effective way to regulate REM sleep alteration.

Joint Pain and Inflammation

55 percent of users use CBD products for joint pain and inflammation. Dr. Sheng-Ming Dai of China’s

Second Military Medical University found CB2 receptors are found in unusually high levels in the joint

tissues of arthritis patients. Further, the Rheumatology article explains the use of cannabis fights

inflammation in joints by activating CB2 receptors.

Depression

49 percent consume hemp-derived CBD for depression. When administered CBD, animal subjects in a

study showed to have fewer instances of anxiety and depression. The study tested animals in various

scenarios such as the forced swimming test (FST), elevated plus maze (EPM) and Vogel conflict test (VCT).

Results suggest that CBD exhibited anti-anxiety and antidepressant effects.

Effectiveness

84 percent of the survey participants find hemp-derived CBD products to be either extremely effective or

very effective. No one finds CBD to have any effect at all. In comparison to CBD-dominant products and

marijuana-derived products, hemp-derived CBD products were almost just as effective if not more as

alternatives.

12 | P a g e

APPENDIX B

Above, a rendition of Jatro’s bench-top pilot hemp to oil extraction system that will be fully

commercialized by the end of 2019.

Jatro Renewables’ engineering and corporate offices at Miamisburg, near Dayton, Ohio.

13 | P a g e

APPENDIX C

DETAILED PROJECT TIME-LINE

14 | P a g e

APPENDIX D - 15% ANNUAL GROWTH

Proforma - 5 Years

2019/20 2021 2022 2023 2024

REVENUE # of Items @ 1 g 15% 28,725 33,034 37,989 43,687 50,240

Items Sold per Day

79 91 104 120 138

Revenue per Item -5% 75 71.25 67.6875 64.303125 61.0879688

Total Retail

2,154,375 2,353,655 2,571,368 2,809,219 3,069,072

Wholesale 15% Other

Sub-Total Revenue

2,154,375 2,353,655 2,571,368 2,809,219 3,069,072

COST OF GOODS SOLD Hemp Per lb -5% $45 43 41 39 37

Hemp lbs

633 728 837 963 1,108

Hemp, Raw $

$28,497 31,133 34,013 37,159 40,596

Labor 5% $288,000 302,400 317,520 333,396 350,066

Power 10% $75,179 82,696 90,966 100,063 110,069

Chemicals 10% $37,589 41,348 45,483 50,031 55,034

Maintenance 10% $28,800 30,240 31,752 33,340 35,007

Product Package 1 28,725 33,034 37,989 43,687 50,240

Sub-Total COGS

$486,790 520,851 557,723 597,676 641,012

RETAIL COSTS

Internet Maint. 10% $54,000 59,400 65,340 71,874 79,061

Internet Advertising 5% $180,000 189,000 198,450 208,373 218,791

Website Mgt. 5% $24,000 25,200 26,460 27,783 29,172

Sub-Total Retail

258,000 273,600 290,250 308,030 327,025

G&A.

Accounting

$84,000 92,400 101,640 111,804 122,984

Insurance

$18,000 19,800 21,780 23,958 26,354

Management

$300,000 330,000 363,000 399,300 439,230

SS, Payroll Taxes 30% 201,600 217,440 282,672 367,474 477,716

Engineering/R&D 5% $185,655 194,938 204,685 214,919 225,665 Extraction Equiment Lease 0% $56,400 56,400 56,400 56,400 56,400

Sub-Total G&A

$845,655 910,978 1,030,177 1,173,854 1,348,349

SUMMARY

EBITDA

563,930 648,226 693,218 729,660 752,686

% of Revenue

26% 28% 27% 26% 25%

15 | P a g e

APPENDIX D - 25% ANNUAL GROWTH

Proforma - 5 Years

2019/20 2021 2022 2023 2024

REVENUE # of Items @ 1 g 25% 28,725 35,906 44,883 56,104 70,129

Items Sold per Day

79 98 123 154 192

Revenue per Item -5% 75 71.25 67.6875 64.303125 61.0879688

Total Retail

2,154,375 2,558,320 3,038,005 3,607,631 4,284,062

Wholesale 15% Other

Sub-Total Revenue

2,154,375 2,558,320 3,038,005 3,607,631 4,284,062

COST OF GOODS SOLD Hemp Per lb -5% $45 $43 $41 $39 $37

Hemp lbs

633 792 989 1,237 1,546

Hemp, Raw $

$28,497 33,840 40,185 47,720 56,667

Labor 5% $288,000 $302,400 $317,520 $333,396 $350,066

Power 10% $75,179 $82,696 $90,966 $100,063 $110,069

Chemicals 10% $37,589 $41,348 $45,483 $50,031 $55,034

Maintenance 10% $28,800 $30,240 $31,752 $33,340 $35,007

Product Package 1 28,725 35,906 44,883 56,104 70,129

Sub-Total COGS

$486,790 $526,431 $570,789 $620,653 $676,973

RETAIL COSTS

Internet Maint. 10% $54,000 59,400 65,340 71,874 79,061

Internet Advertising 5% $180,000 189,000 198,450 208,373 218,791

Website Mgt. 5% $24,000 25,200 26,460 27,783 29,172

Sub-Total Retail

258,000 273,600 290,250 308,030 327,025

G&A.

Accounting

$84,000 92,400 101,640 111,804 122,984

Insurance

$18,000 19,800 21,780 23,958 26,354

Management

$300,000 330,000 363,000 399,300 439,230

SS, Payroll Taxes 30% 201,600 217,440 282,672 367,474 477,716

Engineering/R&D 5% $185,655 194,938 204,685 214,919 225,665 Extraction Equiment Lease 0% $56,400 56,400 56,400 56,400 56,400

Sub-Total G&A

$845,655 $910,978 $1,030,177 $1,173,854 $1,348,349

SUMMARY

EBITDA

563,930 847,311 1,146,790 1,505,094 1,931,716

% of Revenue

26% 33% 38% 42% 45%

16 | P a g e

APPENDIX D - 40% ANNUAL GROWTH

Proforma - 5 Years

2019/20 2021 2022 2023 2024

REVENUE # of Items @ 1 g 40% 28,725 40,215 56,301 78,821 110,350

Items Sold per Day

79 110 154 216 302

Revenue per Item -5% 75 71.25 67.6875 64.303125 61.0879688

Total Retail

2,154,375 2,865,319 3,810,874 5,068,462 6,741,055

Wholesale 15% Other

Sub-Total Revenue

2,154,375 2,865,319 3,810,874 5,068,462 6,741,055

COST OF GOODS SOLD Hemp Per lb -5% $45 $43 $41 $39 $37

Hemp lbs

633 887 1,241 1,738 2,433

Hemp, Raw $

$28,497 37,901 50,408 67,043 89,167

Labor 5% $288,000 302,400 317,520 333,396 350,066

Power 5% $75,179 78,938 82,884 87,029 91,380

Chemicals 5% $37,589 39,469 41,442 43,514 45,690

Maintenance 10% $28,800 30,240 31,752 33,340 35,007

Product Package 1 $28,725 40,215 56,301 78,821 110,350

Sub-Total COGS $486,790 529,162 580,308 643,143 721,660

RETAIL COSTS

Internet Maint. 10% $54,000 59,400 65,340 71,874 79,061

Internet Advertising 15% $180,000 207,000 238,050 273,758 314,821

Website Mgt. 5% $24,000 25,200 26,460 27,783 29,172

Sub-Total Retail $258,000 291,600 329,850 373,415 423,055

G&A.

Accounting

$84,000 92,400 101,640 111,804 122,984

Insurance

$18,000 19,800 21,780 23,958 26,354

Management

$300,000 330,000 363,000 399,300 439,230

SS, Payroll Taxes 30% $201,600 217,440 282,672 367,474 477,716

Engineering/R&D 5% $185,655 194,938 204,685 214,919 225,665 Extraction Equiment Lease 0% $56,400 56,400 56,400 56,400 56,400

Sub-Total G&A $845,655 910,978 1,030,177 1,173,854 1,348,349

SUMMARY

EBITDA $563,930 1,133,579 1,870,539 2,878,050 4,247,992

% of Revenue

26% 40% 49% 57% 63%

17 | P a g e

APPENDIX E - CBD PRODUCTS GALLERY

The graphic below is a concept-only rendition of how Jatro’s products might be look when marketed.

The company name “JatroHempCompany.Com” and “LoveCBD.Club” are just ideas at this point; however,

both domains have been registered in case they are used.

18 | P a g e

APPENDIX F - CULTIVATION, GROWING

The series of photos below show an area 45 miles east of San Diego, where the Company could develop

hemp cultivars and start commercial growing. The land is mainly used for grapes but several acres could

be set aside for high quality CBD oil.

The turn-around time for hemp is 14 weeks from seed to harvest. It’s anticipated that one acre with two

to three crops per year will yield 340,200,000 mg of CBD (750 lbs) after extraction.

Also, the typical high water costs in California are somewhat mitigated here as the land is served by an

endowed well. This provides the 20” of water hemp needs annually

Now consider the financial potential: as of 2/19 the retail price for a 1,000 mg product of CBD (in bottles,

topicals, gummies etc.) is about $0.07/mg. This becomes: 340,200,000 mg of CBD product sales x the

retail cost at $0.07/mg = $23,814,000 per year. Not a bad year’s work!

(Below) the winery’s location at 1910 Buckman Springs Road, Campo and four miles from the Mexico/USA

border.

19 | P a g e

20 | P a g e